Keren Kocshitzki
Directeur Financier/CFO chez FutuRx Ltd.
Profil
Keren Kocshitzki is currently the Director at GliXogen Therapeutics Ltd.
and the Chief Finance Officer at FutuRx Ltd.
She completed her undergraduate and graduate degrees at Ben-Gurion University of the Negev in 2000.
Postes actifs de Keren Kocshitzki
Sociétés | Poste | Début |
---|---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Directeur Financier/CFO | 01/05/2018 |
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Directeur/Membre du Conseil | 17/01/2019 |
Formation de Keren Kocshitzki
Ben-Gurion University of the Negev | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |